Literature DB >> 15698402

In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.

Hidetaka Takashima1, Tomoki Nakajima, Michihisa Moriguchi, Satoru Sekoguchi, Taichiroh Nishikawa, Tadashi Watanabe, Tatsuo Katagishi, Hiroyuki Kimura, Masahito Minami, Yoshito Itoh, Keizo Kagawa, Takeshi Okanoue.   

Abstract

AIM: Our aim was to clarify the significance of expression levels and post-transcriptional splicing patterns of survivin during multistep hepatocarcinogenesis and tumor progression.
METHODS: Using immunohistochemistry, we first elucidated the expression of survivin protein in tissues of hepatocellular carcinoma (HCC) and the adjacent non-cancerous tissues. Furthermore, we investigated survivin gene expression patterns in these tissues.
RESULTS: Survivin protein was expressed not only in most HCC tissues but also in some cirrhotic nodules. In non-cancerous regions, the levels of survivin mRNA increased in proportion to their stage of progression. Survivin protein was expressed mainly in periportal areas, where proliferating cells were localized. In HCC, mRNA levels of survivin and survivin Delta Ex3 correlated with high proliferative activity, whereas the levels of surviving 2B did not. DISCUSSION: These findings of mRNA and protein expressions of survivin in chronically injured avers indicate that it has an important role in hepatocarcinogenesis. A lack of correlation between proliferative activity and survivin 2B mRNA levels in HCC is suggestive of a previous hypothesis that this variant decreases sruvivin function in a dominant negative manner. Thus, our data suggest different functions of these splicing variants and their important roles in tumor progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15698402     DOI: 10.1111/j.1478-3231.2004.0979.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  10 in total

1.  Survivin is not a promising serological maker for the diagnosis of hepatocellular carcinoma.

Authors:  Xiaobo Jia; Yingtang Gao; Daokuan Zhai; Jiao Liu; Yajie Wang; L I Jing; Zhi DU
Journal:  Oncol Lett       Date:  2015-03-17       Impact factor: 2.967

2.  Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo.

Authors:  Robert A Fenstermaker; Sheila A Figel; Jingxin Qiu; Tara A Barone; Sanam S Dharma; Evan K Winograd; Phillip M Galbo; Laura M Wiltsie; Michael J Ciesielski
Journal:  Clin Cancer Res       Date:  2018-03-14       Impact factor: 12.531

Review 3.  Multifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful?

Authors:  Natale D'Alessandro; Paola Poma; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

4.  Changes in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats.

Authors:  Judit Marsillach; Natàlia Ferré; Jordi Camps; Anna Rull; Raul Beltran; Jorge Joven
Journal:  Mol Cell Biochem       Date:  2007-10-16       Impact factor: 3.396

5.  Survivin expression in colorectal carcinomas: correlations with clinicopathological parameters and survival.

Authors:  J G Kalliakmanis; Ch Kouvidou; C Latoufis; G Kouvatseas; D Anagnostakis; G Papatheodoridis; J Koskinas; A Archimandritis
Journal:  Dig Dis Sci       Date:  2009-12-24       Impact factor: 3.199

6.  The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  Sho Mokuda; Tatsuhiko Miyazaki; Yuki Ito; Satoshi Yamasaki; Hiroko Inoue; Yun Guo; Weng-Sheng Kong; Masamoto Kanno; Kiyoshi Takasugi; Eiji Sugiyama; Junya Masumoto
Journal:  Sci Rep       Date:  2015-05-22       Impact factor: 4.379

7.  DEIsoM: a hierarchical Bayesian model for identifying differentially expressed isoforms using biological replicates.

Authors:  Hao Peng; Yifan Yang; Shandian Zhe; Jian Wang; Michael Gribskov; Yuan Qi
Journal:  Bioinformatics       Date:  2017-10-01       Impact factor: 6.937

8.  Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.

Authors:  Claudia Augello; Luca Caruso; Marco Maggioni; Matteo Donadon; Marco Montorsi; Roberto Santambrogio; Guido Torzilli; Valentina Vaira; Caterina Pellegrini; Massimo Roncalli; Guido Coggi; Silvano Bosari
Journal:  BMC Cancer       Date:  2009-04-27       Impact factor: 4.430

9.  Effect of survivin regulation of transcription level by p21waf1 overexpression in HepG2 hepatocellular carcinoma cells.

Authors:  Juan Xiong; Lihua Hu; Yirong Li; Lifang Dou; Pengcheng Cai; Zhaoming Tang; Lin Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

10.  The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers.

Authors:  J Nakano; C Huang; D Liu; D Masuya; H Yokomise; M Ueno; R Haba; S Sumitomo
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.